of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00925717

Acronym

DART

Enrollment

4045

Registered

2009-06-22

Start date

2009-05-31

Completion date

2009-10-31

Last updated

2010-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Density Lipoprotein Cholesterol Goal Achievement

Keywords

ADA recommendation

Brief summary

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects who was diagnosed as diabetes * Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication * Clinic visit in the past 6 months more than once

Exclusion criteria

* Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Design outcomes

Primary

Measure	Time frame
Investigate LDL-C goal achievement rate according to ADA recommendation	Within the last 6 months from the date of data entry.

Secondary

Measure	Time frame
Investigate reduction of 10-year risk for CHD by using UKPDS risk engine	Within the last 6 months from the date of data entry.

Countries

South Korea

Outcome results